CPT code 81007 identifies a laboratory method that detects the presence or absence of bacteriuria using a nonculture, nondipstick technique on a typically random urine specimen. This code is used for rapid screening when culture-based methods are not requested, and it serves an important role in outpatient and clinical laboratory workflows where quick determinations of bacteriuria can inform further diagnostic steps.

Key payers included in coverage discussions are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, typical sites of service, and how it is classified within CPT. The publication outlines common billing considerations and related administrative elements, with benchmarks and policy updates where available. The content also highlights operational implications for laboratories and outpatient facilities, including typical use cases and limitations of a nonculture, nondipstick approach.

This national-level summary is intended to help payers, billing staff, and clinical administrators understand when CPT code 81007 is applied, what it represents clinically, and what topics—such as reimbursement benchmarks, coding guidance, and clinical relevance—are covered in the full analysis.